{
    "nctId": "NCT06483997",
    "briefTitle": "Diet, Hepcidin, and Chemotherapy RDI",
    "officialTitle": "Associations Between Diet, Hepcidin, and Relative Dose Intensity Among Women Receiving Chemotherapy for Breast or Gynecological Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Female, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Endometrial Cancer, Gynecologic Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Serum hepcidin concentration",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Have been diagnosed with invasive breast cancer, OR\n* Have been diagnosed with epithelial ovarian cancer, fallopian tube or primary peritoneal cancer, OR\n* Have been diagnosed with endometrial cancer\n* Are chemotherapy-na\u00efve\n* Are scheduled to receive neoadjuvant chemotherapy (or adjuvant chemotherapy following lumpectomy for breast cancer patients) or neoadjuvant/induction chemotherapy for gynecological cancer at GW Cancer Center\n\nExclusion Criteria:\n\n* Prior primary hematological condition that would cause abnormal blood counts (e.g. leukemia)\n* Pregnant at the time of potential enrollment\n* Receipt of erythropoietin-stimulating agents or blood transfusion in the 6 weeks prior to initial testing\n* Women who are cognitively unable to provide a diet history for the month prior to assessment.",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}